Insider Shareholders with Direct Ownership of Akero Therapeutics, Inc. (AKRO)
This section provides a comprehensive overview of the insiders with direct ownership of Akero Therapeutics, Inc. (AKRO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akero Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew Cheng
President and CEO |
1,252,739 | 1,089,808 | 490,757 $21.9 Million | 96 |
Aug 11, 2025
Reduced 0.08%
|
|
Jonathan Young
Chief Operating Officer |
395,217 | 384,300 | 197,484 $8.81 Million | 62 |
Sep 02, 2025
Reduced 0.03%
|
|
Timothy Rolph
Chief Scientific Officer |
322,816 | 409,130 | 167,124 $7.46 Million | 60 |
Aug 05, 2025
Reduced 4.0%
|
| 9,398 | 169,065 | 145,699 $6.5 Million | 6 |
Jun 03, 2025
Added 6.06%
|
|
|
Catriona Yale
Chief Development Officer |
370,324 | 444,017 | 91,488 $4.08 Million | 77 |
Jul 16, 2025
Reduced 1.45%
|
|
William Richard White
Chief Financial Officer |
558,971 | 502,592 | 58,411 $2.61 Million | 59 |
Jun 30, 2025
Added 1.5%
|
|
Patrick Lamy
Senior VP, Commercial Strategy |
59,618 | 30,288 | 29,891 $1.33 Million | 23 |
Jul 01, 2025
Reduced 6.27%
|
|
Scott A. Gangloff
Chief Technology Officer |
27,199 | 848 | 26,351 $1.18 Million | 4 |
Aug 15, 2025
Added 8.98%
|
| 9,398 | 0 | 11,566 $516,074 | 1 |
Jun 03, 2025
Added 44.83%
|
|
| 35,398 | 26,000 | 9,398 $419,338 | 3 |
Jun 03, 2025
Added 50.0%
|
|
| 9,398 | 0 | 9,398 $419,338 | 1 |
Jun 03, 2025
Added 50.0%
|
|
| 52,398 | 43,000 | 9,398 $419,338 | 5 |
Aug 12, 2025
Reduced 24.2%
|
|
| 9,398 | 0 | 9,398 $419,338 | 1 |
Jun 03, 2025
Added 50.0%
|
|
| 9,398 | 0 | 9,398 $419,338 | 1 |
Jun 03, 2025
Added 50.0%
|
|
|
Apple Tree Partners Iv, L.P.
> 10% Shareholder |
0 | 5,830,203 | 0 $0 | 1 |
Jun 28, 2021
Reduced 100.0%
|